InsiderTrades

Form 4 for CRL Charles River Laboratories

Accepted 2023-01-31 00:00:00 ET · period of report 2022-06-06 · accession 0001127602-23-002783 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2023-01-31 2023-01-27 CRL FOSTER JAMES C COB, Pres, CEO, Dir F - Tax $0.00 -21.5K 232.9K -8% $0
2023-01-31 2023-01-27 CRL FOSTER JAMES C COB, Pres, CEO, Dir A - Grant $0.00 +49.7K 254.4K +24% $0
2023-01-31 2022-06-06 CRL FOSTER JAMES C COB, Pres, CEO, Dir G - Gift $0.00 -2,000 211.7K -0.9% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-01-27 F D 21,453 $0.00 232,922 D — — (F2) On 10/11/2022, the reporting person contributed 11,000 shares of CRL Common Stock to a grantor retained annuity trust for the benefit of himself and his adult children. (F1) On 06/07/2022: 3,939 shares were transferred from the 2020 GRAT account to Direct Holdings.
2 Common Common Stock 2023-01-27 A A 49,725 $0.00 254,375 D — — (F3) Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 29, 2020. (F2) On 10/11/2022, the reporting person contributed 11,000 shares of CRL Common Stock to a grantor retained annuity trust for the benefit of himself and his adult children. (F1) On 06/07/2022: 3,939 shares were transferred from the 2020 GRAT account to Direct Holdings.
3 Common Common Stock 2022-06-06 G D 2,000 $0.00 211,711 D — — (F2) On 10/11/2022, the reporting person contributed 11,000 shares of CRL Common Stock to a grantor retained annuity trust for the benefit of himself and his adult children. (F1) On 06/07/2022: 3,939 shares were transferred from the 2020 GRAT account to Direct Holdings.